HUSSMAN STRATEGIC ADVISORS, INC. - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 211 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
HUSSMAN STRATEGIC ADVISORS, INC. ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$3,411,450
+61.2%
105,000
+25.0%
0.94%
+91.1%
Q1 2024$2,115,960
+24.1%
84,000
+60.0%
0.49%
+26.8%
Q4 2023$1,705,200
-0.7%
52,500
-16.7%
0.39%
+18.3%
Q3 2023$1,716,435
-17.6%
63,000
-32.7%
0.33%
-14.4%
Q2 2023$2,082,600
-13.8%
93,600
-16.1%
0.38%
+1.1%
Q1 2023$2,417,256
+28.0%
111,600
+20.0%
0.38%
+23.1%
Q4 2022$1,888,830
-40.6%
93,000
-25.0%
0.31%
-43.9%
Q3 2022$3,179,000
-4.2%
124,000
-11.1%
0.55%
-4.0%
Q2 2022$3,317,000
+183.3%
139,500
+168.3%
0.57%
+152.0%
Q1 2022$1,171,000
+13.7%
52,0000.0%0.23%
+0.4%
Q4 2021$1,030,000
-66.2%
52,000
-66.5%
0.23%
-66.4%
Q3 2021$3,050,000
+49.1%
155,000
+66.7%
0.67%
+58.5%
Q2 2021$2,046,000
+19.4%
93,000
+29.2%
0.42%
+20.1%
Q1 2021$1,713,000
-54.4%
72,000
-49.8%
0.35%
-64.1%
Q4 2020$3,754,000
-15.4%
143,500
-43.7%
0.98%
-16.2%
Q3 2020$4,438,000
+46.6%
255,000
+41.7%
1.17%
+52.1%
Q2 2020$3,028,000
+65.4%
180,000
+16.9%
0.77%
+56.3%
Q1 2020$1,831,000
+47.7%
154,000
+50.2%
0.49%
+25.1%
Q4 2019$1,240,000
+43.2%
102,500
+67.2%
0.40%
+61.2%
Q3 2019$866,000
-55.9%
61,296
-51.0%
0.24%
-53.7%
Q2 2018$1,965,000125,0000.53%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,372,001$98,287,0004.68%
TANAKA CAPITAL MANAGEMENT INC 79,574$934,0002.82%
Consonance Capital Management LP 3,747,453$43,995,0002.78%
S&T BANK/PA 613,740$7,205,0001.62%
AJ WEALTH STRATEGIES, LLC 595,834$6,995,0001.16%
Capital Impact Advisors, LLC 193,694$2,522,0001.12%
TEALWOOD ASSET MANAGEMENT INC 154,615$1,815,0000.77%
AMI ASSET MANAGEMENT CORP 722,932$8,487,0000.63%
Birchview Capital, LP 50,000$587,0000.37%
FEDERATED HERMES, INC. 11,176,281$131,210,0000.32%
View complete list of CORCEPT THERAPEUTICS INC shareholders